Loading…
RU-486 Suspension and Review Act of 2005
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 4,105 other S bills in the 109th — cohort avg 35d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2006 · year_end · Pharmacy
PHA HR 1079 RU-486 Suspension and Review Act of 2005 Approved application for RU-486 withdrawn for review PHA S 511 RU-486 Suspension and Review Act of 2005 Application for RU-486 withdrawn for review
Client expense: $20,000 · Firm income: Not reported
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2006 · year_end · Family issues/Abortion/Adoption
Support: S. 8, S. 403, HR 748 (parental notification); HR 552 (Respect Life Act); (continued) (continued) S. 1983 (ANDA); HR 216/S.755 (ultrasound grants); HR 1079/S.511 (RU-486); HR 356, HR 6099, S. 51 (Unborn Child Pain Awareness Act); defense of PL-108-105; HR 4265 S. 1966 (Stanton program); S. 2203 (Title X reform). Oppose: HR 3746 (Hoyer phony ban), S. 2593/HR 5151 (FOCA).
Client expense: $184,455 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Vice President of the U.S.
2006 · year_end · Medical/Disease Research/Clinical Labs
Support: HR 1357 and S. 658 (bans on human cloning); (continued) (continued) HR 356, HR 6099, S. 51 (Unborn Child Pain Awareness); S. 2754 /HR 5526 (alternative sources of pluripotent stem cells); S. 3504/HR 5719 (Fetus Farming Prohibition). Oppose: HR 1822, HR 3932, S. 876, S. 1520, bills to authorize human clone-and-kill policy. Oppose: HR 810/S.471 to mandate federal funding of research that requires the killing of human embryos. Support for executive policies consistent with the above. Support: HR 216/S.755 (grants for ultrasound equipment); HR 1079/S. 511 (restrictions on RU-486 abortion pill); S. 2206 (Title X reform). Support retention of Weldon provision of HR 5672 (to bar patents on human organisms).
Client expense: $184,455 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Vice President of the U.S.
2006 · year_end · Pharmacy
In support of HR 1079, S. 511, S. 3939 (regulations pertaining to RU-486 abortion pill).
Client expense: $184,455 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Vice President of the U.S.
2005 · year_end · Pharmacy
S 511 RU-486 Suspension and Review Act of 2005 Application for RU-486 withdrawn for review
Client expense: $60,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
| Republican |
| KY |
| John Ensign | Republican | NV |
| John Thune | Republican | SD |
| Mel Martinez | Republican | FL |
| Michael B. Enzi | Republican | WY |
| Michael DeWine | Republican | OH |
| Richard Santorum | Republican | PA |
| Samuel Brownback | Republican | KS |
| Tom Coburn | Republican | OK |